Vanderbilt research contributed to first COVID-19 pill now under review

The drug, known as molnupiravir, was first shown to be efficacious against coronaviruses, including the COVID-19 virus, SARS-CoV-2, by investigators at Vanderbilt University Medical Center.

Related Keywords

Timothy Sheahan ,Mark Denison ,Andrea Pruijssers ,Edward Claiborne Stahlman ,Emory Institute For Drug Development ,Vanderbilt University Medical Center ,University Of North Carolina At Chapel Hill ,National Institutes Of Health ,Drug Administration ,Merck Co ,North Carolina ,Memory Institute ,Drug Development ,Miami Based Ridgeback Therapeutics ,Edward Claiborne Stahlman Chair ,Pediatric Physiology ,Cell Metabolism ,Ralph Baric ,National Institutes ,Health Care ,Wellness ,